Bill
SB 629
Prohibits gender-transition surgeries, therapies, and related care for individuals under 18.
SB 629 (West Virginia, 2026) — Prohibiting gender transition surgeries, treatments, and therapies to minors
Overview
- Purpose: This bill aims to restrict or ban gender-transition related medical interventions for individuals under the age of 18. It seeks to prevent minors from receiving certain medical treatments or therapies that are intended to alter or affirm gender identity, including surgical procedures, medical therapies, and related services.
- Status and process: Introduced in the Senate on January 27, 2026. Referred to Health and Human Resources, with a subsequent referral to Judiciary. Co-sponsored by Senator Mike Azinger.
What the bill would do (key provisions)
- Prohibition scope:
- Likely prohibits gender-transition surgeries for minors. This includes procedures intended to alter primary or secondary sex characteristics.
- Likely prohibits, or restricts, medical therapies used to treat gender dysphoria in minors. This may include puberty blockers, hormone therapies (such as estrogen or testosterone), and other pharmacological or medical interventions used to align an individual’s physical characteristics with their gender identity, for those under 18.
- Potential bans or restrictions on related counseling or therapy that is specifically aimed at facilitating gender transition in minors. (The text provided is not fully legible, but the bill’s title and typical structure suggest prohibitions on medical treatments rather than non-medical counseling.)
- Age and eligibility:
- Applies to individuals under 18. The bill would define “minor” accordingly and set thresholds for what constitutes an actionable medical intervention.
Who would be affected
- Minors seeking gender-affirming medical care:
- Pediatric patients and their families who might otherwise pursue puberty blockers, cross-sex hormones, surgical procedures, or related therapies.
- Medical providers:
- Pediatricians, pediatric endocrinologists, surgeons, and other clinicians who would be restricted from providing these specific interventions to minors.
- Institutions and programs:
- Health care facilities, clinics, and possibly insurers that cover or provide gender-affirming care to minors could be affected, with requirements or prohibitions limiting such services for those under 18.
- Families and guardians:
- Parents or guardians who seek to obtain or consent to gender-affirming treatments for their minor children.
Procedural and timeline aspects
- First step: Bill introduced in the Senate on January 27, 2026.
- Committee path: Referred to Health and Human Resources, then to Judiciary, indicating hearings and potential amendments before advancing.
- Potential implementation: If enacted, the bill would typically include effective dates (e.g., immediate upon passage or a specified future date) and may include transition provisions for ongoing care, if applicable.
Notes and considerations
- The summary reflects the bill’s stated title and the typical content of similar bills. The exact language would determine precise definitions (e.g., what constitutes “gender transition surgeries,” what constitutes “treatment” or “therapy”), enforcement mechanisms, penalties, exemptions (e.g., for patients with specific medical conditions), and any regulatory conflict with federal or state medical practice laws.
- No dollar amounts, penalties, or enforcement details are provided in the available text. The final version would clarify these elements, including any exceptions for minors with certain medical indications or for trials/pharmacological protocols.
If you’d like, I can tailor this summary to include a more detailed section-by-section breakdown once the official bill text is available, or compare it to similar enacted or proposed bills in other states.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
